Send feedback

CLPB p.Arg332Gln

c.995G>A · rs759536311 · VCV2440149

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely pathogenic
0.9573 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00223%, eas)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
3-methylglutaconic aciduria, type VIIB

Computational evidence

Protein change
AlphaMissense0.9573likely pathogenic
REVEL0.389indeterminate
SaProtLLR -13.05damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.7GERP 1.6, phastCons 1
Regional constrainto/e 0.54unconstrained · MANE · 22 kb · p 2.6e-09 · regional, not allelic
Overall
CADD33.0PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM R362Q vs ClinVar R332Q) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00223% East Asian · 1/44,884 alleles
Filtering AF 0.000292% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000211%
Overall 0.000889% 13/1,461,728 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0032% 31,252
East Asiangrpmax 0.00223% 44,884
African / African-American 0.00133% 75,048
South Asian 0.0011% 91,076
European (non-Finnish) 0.000678% 147,486

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CLPB
Protein
p.Arg332Gln
Coding
c.995G>A
MANE Select
NM_001258392
dbSNP
rs759536311
Type
single nucleotide variant
Location
chr11:72308598 (GRCh38)
Gene constraint
LOEUF 0.643 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 72.52 · 7 PDB
Residue 332
an α-helix
Full CLPB gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

3-methylglutaconic aciduria, type VIIB — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For 3-methylglutaconic aciduria-neonatal cataract-neurologic involvement-congenital neutropenia syndrome (Orphanet):

Inheritance
Autosomal recessive
Onset
Antenatal, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/clpb-p-arg332gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown